QIAGEN NV's ticker is and the CUSIP is N72482AA5. A total of 18 filers reported holding QIAGEN NV in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $59,159,000 | +6.9% | 48,800,000 | +16.7% | 1.75% | +33.0% |
| Q3 2018 | $55,338,000 | +26.9% | 41,800,000 | +22.2% | 1.31% | +49.8% |
| Q2 2018 | $43,605,000 | +68.2% | 34,200,000 | +55.5% | 0.88% | +109.3% |
| Q1 2018 | $25,930,000 | -6.4% | 22,000,000 | -8.3% | 0.42% | -15.2% |
| Q4 2017 | $27,702,000 | -0.8% | 24,000,000 | 0.0% | 0.49% | +18.2% |
| Q3 2017 | $27,930,000 | +3.5% | 24,000,000 | +9.1% | 0.42% | +4.0% |
| Q2 2017 | $26,978,000 | – | 22,000,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Myriad Asset Management Ltd. | 30,000,000 | $38,186,000 | 8.14% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 40,800,000 | $49,521,000 | 3.27% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 48,800,000 | $59,159,000 | 1.75% |
| EXANE DERIVATIVES | 11 | $2,634,132,000 | 0.47% |
| Verition Fund Management LLC | 50,000 | $5,972,000 | 0.43% |
| BlueCrest Capital Management Ltd | 6,600,000 | $7,893,000 | 0.41% |
| CQS Cayman LP | 4,200,000 | $5,015,000 | 0.34% |
| SG Americas Securities, LLC | 128,000 | $15,413,000 | 0.14% |
| OAKTREE CAPITAL MANAGEMENT LP | 4,400,000 | $5,252,000 | 0.05% |
| HSBC HOLDINGS PLC | 190,702 | $22,777,000 | 0.04% |